Patents by Inventor Kazuyuki Yoshizaki

Kazuyuki Yoshizaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7320792
    Abstract: A preventive and therapeutic agent for psoriasis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.
    Type: Grant
    Filed: October 25, 2001
    Date of Patent: January 22, 2008
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Hiroaki Ito, Kazuyuki Yoshizaki, Norihiro Nishimoto, Tadamitsu Kishimoto, Shin Shimaoka, Hidetomo Kitamura, Masamichi Sugimoto, Kenichi Akamatsu
  • Publication number: 20070243189
    Abstract: A blood vascular endothelial growth factor (VEGF) level-lowering agent comprising an interleukin-6 (IL-6) antagonist as an active ingredient.
    Type: Application
    Filed: June 18, 2007
    Publication date: October 18, 2007
    Inventors: Kazuyuki Yoshizaki, Norihiro Nishimoto
  • Publication number: 20070148169
    Abstract: A therapeutic agent for chronic arthritides diseases of childhood-related diseases, for example chronic arthritides diseases of childhood, Still's disease and the like, comprising an interleukin-6 (IL-6) antagonist as an active ingredient.
    Type: Application
    Filed: February 9, 2007
    Publication date: June 28, 2007
    Inventors: Kazuyuki Yoshizaki, Norihiro Nishimoto, Masahiro Iwamoto, Seiji Minota, Shumpei Yokota, Takako Miyamae
  • Publication number: 20060292147
    Abstract: A blood matrix metalloprotease-3 (MMP-3) level-lowering agent comprising an interleukin-6 (IL-6) antagonist as an active ingredient.
    Type: Application
    Filed: September 1, 2006
    Publication date: December 28, 2006
    Inventors: Kazuyuki Yoshizaki, Norihiro Nishimoto, Yasunori Okada, Ken-ichi Obata
  • Publication number: 20060240012
    Abstract: A substance effective for treating immunopathy where interleukin 6 (IL-6) is involved is provided. A human anti-human IL-6 antibody and a human anti-human IL-6 antibody fragment having a high affinity to human IL-6 were obtained using phage antibody technique. Said antibody and antibody fragment are expected to be useful as a medicament for treating inflammation and immunopathy caused by IL-6.
    Type: Application
    Filed: August 28, 2003
    Publication date: October 26, 2006
    Applicant: Juridical Foundation the Chemo-Sero-Therapeutic Research Institute
    Inventors: Kazuhisa Sugimura, Kazuyuki Yoshizaki, Toshihiro Nakashima, Takumi Sasaki
  • Publication number: 20060165696
    Abstract: A therapeutic agent for spinal cord injury, a modulator of differentiation of neural stem cells and an inhibitor of differentiation into glia cells comprising an interleukin-6 antagonist as an active ingredient.
    Type: Application
    Filed: February 24, 2004
    Publication date: July 27, 2006
    Inventors: Hideyuki Okano, Seiji Okada, Masaya Nakamura, Kazuyuki Yoshizaki
  • Publication number: 20040115197
    Abstract: A therapeutic agent for chronic arthritides diseases of childhood-related diseases, for example chronic arthritides diseases of childhood, Still's disease and the like, comprising an interleukin-6 (IL-6) antagonist as an active ingredient.
    Type: Application
    Filed: September 29, 2003
    Publication date: June 17, 2004
    Inventors: Kazuyuki Yoshizaki, Norihiro Nishimoto, Masahiro Iwamoto, Seiji Minota, Shumpei Yokota, Takako Miyamae
  • Publication number: 20040028681
    Abstract: A preventive and therapeutic agent for psoriasis comprising an interleukin-6 (IL-6) antagonist such as, for example, an antibody against IL-6 receptor.
    Type: Application
    Filed: April 24, 2003
    Publication date: February 12, 2004
    Inventors: Hiroaki Ito, Kazuyuki Yoshizaki, Norihiro Nishimoto, Tadamitsu Kishimoto, Shin Shimaoka, Hidetomo Kitamura, Masamichi Sugimoto, Kenichi Akamatsu